nodes	percent_of_prediction	percent_of_DWPC	metapath
Bedaquiline—CYP3A4—bone cancer	0.976	1	CbGaD
Bedaquiline—Hepatic cirrhosis—Methotrexate—bone cancer	0.00214	0.0912	CcSEcCtD
Bedaquiline—Amylase increased—Cisplatin—bone cancer	0.00157	0.0669	CcSEcCtD
Bedaquiline—Septic shock—Epirubicin—bone cancer	0.00127	0.0542	CcSEcCtD
Bedaquiline—Septic shock—Doxorubicin—bone cancer	0.00118	0.0501	CcSEcCtD
Bedaquiline—Transaminases increased—Epirubicin—bone cancer	0.000632	0.0269	CcSEcCtD
Bedaquiline—Transaminases increased—Doxorubicin—bone cancer	0.000585	0.0249	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Cisplatin—bone cancer	0.000555	0.0236	CcSEcCtD
Bedaquiline—Haemoptysis—Epirubicin—bone cancer	0.000519	0.0221	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000489	0.0208	CcSEcCtD
Bedaquiline—Haemoptysis—Doxorubicin—bone cancer	0.000481	0.0204	CcSEcCtD
Bedaquiline—Hepatic enzyme increased—Methotrexate—bone cancer	0.000434	0.0185	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Cisplatin—bone cancer	0.000396	0.0169	CcSEcCtD
Bedaquiline—Toremifene—CYP3A4—bone cancer	0.000392	0.56	CrCbGaD
Bedaquiline—Connective tissue disorder—Cisplatin—bone cancer	0.000369	0.0157	CcSEcCtD
Bedaquiline—Cardiac disorder—Cisplatin—bone cancer	0.000349	0.0148	CcSEcCtD
Bedaquiline—Arrhythmia—Cisplatin—bone cancer	0.000336	0.0143	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Epirubicin—bone cancer	0.000319	0.0136	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Methotrexate—bone cancer	0.000304	0.0129	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Doxorubicin—bone cancer	0.000295	0.0126	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Epirubicin—bone cancer	0.000285	0.0121	CcSEcCtD
Bedaquiline—Myalgia—Cisplatin—bone cancer	0.000279	0.0119	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Doxorubicin—bone cancer	0.000263	0.0112	CcSEcCtD
Bedaquiline—Nervous system disorder—Cisplatin—bone cancer	0.000262	0.0111	CcSEcCtD
Bedaquiline—Anorexia—Cisplatin—bone cancer	0.000255	0.0108	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000251	0.0107	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000246	0.0105	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000243	0.0104	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000233	0.00989	CcSEcCtD
Bedaquiline—Decreased appetite—Cisplatin—bone cancer	0.000232	0.00988	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Cisplatin—bone cancer	0.000231	0.00981	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000228	0.00969	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Methotrexate—bone cancer	0.000217	0.00925	CcSEcCtD
Bedaquiline—Hepatitis—Methotrexate—bone cancer	0.000206	0.00878	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Epirubicin—bone cancer	0.000203	0.00865	CcSEcCtD
Bedaquiline—Hepatitis—Epirubicin—bone cancer	0.000193	0.00821	CcSEcCtD
Bedaquiline—Cardiac disorder—Methotrexate—bone cancer	0.000191	0.00815	CcSEcCtD
Bedaquiline—Connective tissue disorder—Epirubicin—bone cancer	0.00019	0.00807	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Doxorubicin—bone cancer	0.000188	0.00801	CcSEcCtD
Bedaquiline—Diarrhoea—Cisplatin—bone cancer	0.000183	0.00778	CcSEcCtD
Bedaquiline—Cardiac disorder—Epirubicin—bone cancer	0.000179	0.00762	CcSEcCtD
Bedaquiline—Hepatitis—Doxorubicin—bone cancer	0.000179	0.0076	CcSEcCtD
Bedaquiline—Connective tissue disorder—Doxorubicin—bone cancer	0.000176	0.00747	CcSEcCtD
Bedaquiline—Arrhythmia—Epirubicin—bone cancer	0.000172	0.00734	CcSEcCtD
Bedaquiline—Vomiting—Cisplatin—bone cancer	0.00017	0.00723	CcSEcCtD
Bedaquiline—Rash—Cisplatin—bone cancer	0.000168	0.00717	CcSEcCtD
Bedaquiline—Dermatitis—Cisplatin—bone cancer	0.000168	0.00716	CcSEcCtD
Bedaquiline—Cardiac disorder—Doxorubicin—bone cancer	0.000166	0.00705	CcSEcCtD
Bedaquiline—Arrhythmia—Doxorubicin—bone cancer	0.00016	0.00679	CcSEcCtD
Bedaquiline—Nausea—Cisplatin—bone cancer	0.000159	0.00675	CcSEcCtD
Bedaquiline—Tamoxifen—CYP3A4—bone cancer	0.000156	0.223	CrCbGaD
Bedaquiline—Arthralgia—Methotrexate—bone cancer	0.000153	0.00651	CcSEcCtD
Bedaquiline—Chest pain—Methotrexate—bone cancer	0.000153	0.00651	CcSEcCtD
Bedaquiline—Myalgia—Methotrexate—bone cancer	0.000153	0.00651	CcSEcCtD
Bedaquiline—Orphenadrine—CYP3A4—bone cancer	0.000152	0.217	CrCbGaD
Bedaquiline—Nervous system disorder—Methotrexate—bone cancer	0.000144	0.00612	CcSEcCtD
Bedaquiline—Chest pain—Epirubicin—bone cancer	0.000143	0.00609	CcSEcCtD
Bedaquiline—Arthralgia—Epirubicin—bone cancer	0.000143	0.00609	CcSEcCtD
Bedaquiline—Myalgia—Epirubicin—bone cancer	0.000143	0.00609	CcSEcCtD
Bedaquiline—Anorexia—Methotrexate—bone cancer	0.00014	0.00594	CcSEcCtD
Bedaquiline—Nervous system disorder—Epirubicin—bone cancer	0.000135	0.00572	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000134	0.00568	CcSEcCtD
Bedaquiline—Arthralgia—Doxorubicin—bone cancer	0.000132	0.00563	CcSEcCtD
Bedaquiline—Chest pain—Doxorubicin—bone cancer	0.000132	0.00563	CcSEcCtD
Bedaquiline—Myalgia—Doxorubicin—bone cancer	0.000132	0.00563	CcSEcCtD
Bedaquiline—Anorexia—Epirubicin—bone cancer	0.000131	0.00556	CcSEcCtD
Bedaquiline—Decreased appetite—Methotrexate—bone cancer	0.000127	0.00542	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Methotrexate—bone cancer	0.000127	0.00538	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000125	0.00532	CcSEcCtD
Bedaquiline—Nervous system disorder—Doxorubicin—bone cancer	0.000124	0.0053	CcSEcCtD
Bedaquiline—Anorexia—Doxorubicin—bone cancer	0.000121	0.00515	CcSEcCtD
Bedaquiline—Decreased appetite—Epirubicin—bone cancer	0.000119	0.00507	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Epirubicin—bone cancer	0.000118	0.00504	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000116	0.00492	CcSEcCtD
Bedaquiline—Decreased appetite—Doxorubicin—bone cancer	0.00011	0.00469	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00011	0.00466	CcSEcCtD
Bedaquiline—Diarrhoea—Methotrexate—bone cancer	0.0001	0.00427	CcSEcCtD
Bedaquiline—Dizziness—Methotrexate—bone cancer	9.69e-05	0.00412	CcSEcCtD
Bedaquiline—Diarrhoea—Epirubicin—bone cancer	9.38e-05	0.00399	CcSEcCtD
Bedaquiline—Vomiting—Methotrexate—bone cancer	9.32e-05	0.00397	CcSEcCtD
Bedaquiline—Rash—Methotrexate—bone cancer	9.24e-05	0.00393	CcSEcCtD
Bedaquiline—Dermatitis—Methotrexate—bone cancer	9.23e-05	0.00393	CcSEcCtD
Bedaquiline—Headache—Methotrexate—bone cancer	9.18e-05	0.00391	CcSEcCtD
Bedaquiline—Dizziness—Epirubicin—bone cancer	9.07e-05	0.00386	CcSEcCtD
Bedaquiline—Vomiting—Epirubicin—bone cancer	8.72e-05	0.00371	CcSEcCtD
Bedaquiline—Nausea—Methotrexate—bone cancer	8.71e-05	0.0037	CcSEcCtD
Bedaquiline—Diarrhoea—Doxorubicin—bone cancer	8.68e-05	0.00369	CcSEcCtD
Bedaquiline—Rash—Epirubicin—bone cancer	8.65e-05	0.00368	CcSEcCtD
Bedaquiline—Dermatitis—Epirubicin—bone cancer	8.64e-05	0.00368	CcSEcCtD
Bedaquiline—Headache—Epirubicin—bone cancer	8.59e-05	0.00366	CcSEcCtD
Bedaquiline—Dizziness—Doxorubicin—bone cancer	8.39e-05	0.00357	CcSEcCtD
Bedaquiline—Nausea—Epirubicin—bone cancer	8.15e-05	0.00347	CcSEcCtD
Bedaquiline—Vomiting—Doxorubicin—bone cancer	8.07e-05	0.00343	CcSEcCtD
Bedaquiline—Rash—Doxorubicin—bone cancer	8e-05	0.0034	CcSEcCtD
Bedaquiline—Dermatitis—Doxorubicin—bone cancer	7.99e-05	0.0034	CcSEcCtD
Bedaquiline—Headache—Doxorubicin—bone cancer	7.95e-05	0.00338	CcSEcCtD
Bedaquiline—Nausea—Doxorubicin—bone cancer	7.54e-05	0.00321	CcSEcCtD
